导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -6.74% | 1962/2676 |
| 近一周 | -2.21% | 1934/3004 |
| 近一月 | -1.46% | 624/2984 |
| 近一季 | 0.51% | 525/2896 |
| 近半年 | -5.63% | 1689/2746 |
| 近一年 | -10.19% | 1908/2519 |
| 近两年 | 37.94% | 1200/1796 |
| 近三年 | 35.56% | 485/1340 |
| 成立以来 | 10.53% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-5.03% 3751/4961 |
-8.62% 3905/5312 |
- - |
- - |
| 2025 | 26.70% 1609/4813 |
14.93% 193/3635 |
3.95% 899/4076 |
11.85% 3123/4524 |
-5.19% 3521/4813 |
| 2024 | 23.16% 347/3463 |
-1.49% 1233/2808 |
9.86% 47/3014 |
14.92% 1876/3129 |
-0.97% 1557/3463 |
| 2023 | -10.51% 1311/2656 |
0.32% 1743/2280 |
-0.03% 355/2385 |
-8.23% 1682/2515 |
-2.76% 524/2655 |
| 2022 | -4.73% 104/2207 |
-6.75% 227/1919 |
6.00% 792/2016 |
-14.61% 1125/2113 |
12.88% 117/2208 |
| 2021 | -12.54% 1129/1822 |
4.38% 150/1255 |
0.05% 1115/1330 |
-11.35% 1263/1466 |
-5.53% 1517/1822 |
| 2020 | -5.04% 966/1250 |
-13.33% 163/280 |
5.23% 223/295 |
-7.25% 1131/1164 |
12.25% 487/1184 |
| 2019 | 12.38% 717/1092 |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 景顺长城中证港股通创新药ETF | 1.6507 | 28.23% |
| 港股医疗 | 0.9366 | 28.18% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 港股通医疗ETF工银 | 0.9464 | 28.06% |
| 港股通医疗ETF华宝 | 0.9577 | 27.97% |
| 天弘恒生沪深港创新药精选50ETF发起联接C | 1.2844 | 27.92% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 万家中证港股通创新药ETF发起式联接A | 1.3863 | 27.32% |
| 万家中证港股通创新药ETF发起式联接C | 1.3856 | 27.27% |
| 华夏沪港通恒生ETF联接C VS. 长安沪深300非周期A(740101) |